For Healthcare Providers
Resources for healthcare providers and prescribers on managing drug shortages, helping patients find medications, and savings programs.
2555 articles
Diltiazem XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Diltiazem XR availability in 2026. Covers shortage history, formulation non-interchangeability, prescribing strategies, and patient support tools.
Disulfiram Shortage: What Providers and Prescribers Need to Know in 2026
The disulfiram shortage is impacting AUD patients' access to medication. Providers need to know which presentations are unavailable and how to support patients through the gap.
Dovato (Dolutegravir/Lamivudine) Shortage: What Providers and Prescribers Need to Know in 2026
Dovato isn't in an official shortage, but specialty drug access barriers affect patient adherence. Here's what HIV providers need to know to keep patients on treatment in 2026.
Drysol Availability: What Providers and Prescribers Need to Know in 2026
A clinical update for providers on Drysol (aluminum chloride hexahydrate) availability in 2026, including patient counseling tips and prescribing alternatives.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Dulcolax Shortage: What Providers and Prescribers Need to Know in 2026
Bisacodyl (Dulcolax) tablets are stable, but suppositories face ongoing intermittent shortages. Here's the clinical context, prescribing guidance, and alternatives for providers.
Durezol Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for ophthalmologists and optometrists on the ongoing Durezol (difluprednate) shortage: what's affected, clinical alternatives, prior auth strategies, and patient support resources.
Edluar Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Edluar (zolpidem sublingual) availability in 2026. Covers supply status, prescribing implications, formulary challenges, and clinical alternatives for providers.
Entrectinib Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers on entrectinib (Rozlytrek) availability, prior authorization, patient access barriers, and how to support your patients in 2026.
Ergomar Shortage: What Providers and Prescribers Need to Know in 2026
Ergomar isn't in FDA shortage, but your patients may still struggle to fill it. Here's the clinical and logistical picture for prescribers in 2026.
Estradiol/Norgestimate Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for prescribers on Estradiol/Norgestimate (Prefest) availability issues in 2026, including alternatives, switching strategies, and patient counseling.
Estratest Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Estratest (EEMT) availability challenges in 2026: supply drivers, regulatory considerations, and practical guidance for prescribers managing affected patients.
Evamist Shortage: What Providers and Prescribers Need to Know in 2026
Providers prescribing Evamist in 2026 are encountering unexpected availability challenges. Here's the clinical context, prescribing flexibility, and alternatives your patients may need.